The firm's genomics revenues more than doubled year over year, while data and services revenue increased nearly 36 percent.

The target device includes a portable instrument and 30-minute, $5 assays requiring only small volumes of whole capillary blood.

The test is compatible with lateral flow technology and could be used to provide tuberculosis testing in low-resource settings.

China's volume-based procurement policy and US tariffs have forced companies with large businesses in China to reset their ...

The Johns Hopkins University spinout's MycoMeia Aspergillus Assay is used to aid the diagnosis of the lung disease aspergillosis in immunocompromised patients.

The firm said it is in talks with payors about pilot programs and it expects to soon publish data on the use of its test to improve outcomes and reduce healthcare costs.

Stakeholders suggested that while the FDA rule is dead, updates to LDT regulation are coming, nonetheless, and the industry ...

Some experts believe a technological tipping point is imminent, if not already here, but adoption of point-of-care MDx has ...

Through clinical trials, partnerships, and economic studies, a crop of test developers is trying to prove the value of their ...

The South Korean firm said that its CURECA system offers walkaway PCR testing with 24/7 operation without human intervention ...

Danaher subsidiaries Beckman Coulter, Cepheid, and Leica Biosystems will be working together with external partners to focus ...

The development marks a shift up the value chain for labs and could prove a meaningful revenue stream for providers able to ...